Physician profile
Kyle Gibbens
NPI 1477043800
$2,724.11
in general payments reported to CMS, 2019-2025
32 companies · $640 in 2025
The $640 reported for 2025 was more than what 78% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $195 · 2022: $629 · 2023: $663 · 2024: $596 · 2025: $640.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,776 · Education: $124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,775.68 |
| Education | $123.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $586.69 | 2021-2025 | |
| Amgen INC. | $222.50 | 2021-2024 | Prolia, Evenity, Repatha |
| Astellas Pharma US INC | $179.11 | 2023-2025 | Veozah |
| Pfizer INC. | $178.83 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $136.30 | 2021-2024 | |
| Janssen Pharmaceuticals, INC | $133.11 | 2023-2025 | Invega Sustenna, Spravato |
| Actelion Pharmaceuticals US, INC. | $132.54 | 2023-2025 | Uptravi, Opsumit |
| Novo Nordisk INC | $131.99 | 2021-2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $105.75 | 2021-2025 | Jardiance, Zepbound, Mounjaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $96.16 | 2022-2024 | Jardiance |
| Abbott Laboratories | $92.33 | 2021-2025 | Freestyle Libre 3 |
| Medtronic, INC. | $72.61 | 2021-2025 | Symplicity G3, Kyphon Express II Kyphopak Tray |
| Exact Sciences Corporation | $72.41 | 2024 | Cologuard Collection Kit |
| Biohaven Pharmaceutical Holding Company Ltd. | $69.43 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $67.73 | 2021-2024 | Airsupra |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $62.05 | 2021-2024 | Gardasil 9, Vaxneuvance, Gardasil |
| Itamar Medical INC | $44.45 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $42.09 | 2025 | Caplyta |
| Resmed Corp | $34.98 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $32.96 | 2023-2024 | Xifaxan |
| Boston Scientific Corporation | $31.60 | 2023 | Watchman Flx |
| E.R. Squibb & Sons, L.L.C. | $30.66 | 2022-2025 | Eliquis |
| Mayne Pharma Commercial LLC | $22.46 | 2023 | |
| Otsuka America Pharmaceutical, INC. | $20.86 | 2023 | Rexulti |
| Novartis Pharmaceuticals Corporation | $18.75 | 2024 | |
| Bausch Health US, LLC | $18.35 | 2022 | |
| Ascensia Diabetes Care US INC. | $16.08 | 2024 | |
| Sumitomo Pharma America, INC. | $15.41 | 2025 | Gemtesa |
| Ultragenyx Pharmaceutical INC. | $14.84 | 2022 | |
| Intercept Pharmaceuticals, INC. | $14.67 | 2025 | |
| Corcept Therapeutics | $14.56 | 2025 | Korlym |
| Glaxosmithkline, LLC. | $11.85 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Gibbens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.